Approval · Notice of Compliance 34412 · 2024
FUROSEMIDE INJECTION USP: Notice of Compliance 34412
Issued November 15, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34412
- Date
- November 15, 2024
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and/or manufacturer involving production. Update to Product Monograph (to align with CRP approved PM). Update to package labels. Update to package insert
- Canadian reference product
- FUROSEMIDE INJECTION SDZ (Sandoz Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FUROSEMIDE INJECTION USP | Not yet assigned | — |
Medicinal ingredients
- FUROSEMIDE 10 MG per ML